Sendero Wealth Management, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1639375
SAN ANTONIO, TX
Position in TMO
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$283,769
+$3,107 QoQ
Shares Held
566
-0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,074
of 2,606 holders
Holding Since
Jun 2023
5 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Sendero Wealth Management, LLC holds $26,289,794 across 6 Diagnostics & Research names. TMO ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
47,643 | $9,205,579 | |
| 2 | ICLR |
Icon PLC
|
45,382 | $7,883,306 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
26,137 | $5,927,610 | |
| 4 | DHR |
Danaher Corp /De/
|
11,540 | $2,198,139 | |
| 5 | RVTY |
Revvity, Inc.
|
7,113 | $791,391 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
This page
|
566 | $283,769 |
All Filings in TMO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $283,769 | 566 | Shares | Other | 2026-08-04 | |
| 2026-03-31 | $280,662 | 571 | Shares | Sole | 2026-04-22 | |
| 2023-12-31 | $1,089,180 | 2,052 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,025,500 | 2,026 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,023,151 | 1,961 | Shares | Other | 2023-07-20 | |
| No filing history on record for this holder in this stock. | ||||||